...
首页> 外文期刊>癌と化学療法 >Complete response of primary tumor in a case of advanced gastric cancer with liver metastasis treated by TS-1 plus divided administration of CDDP
【24h】

Complete response of primary tumor in a case of advanced gastric cancer with liver metastasis treated by TS-1 plus divided administration of CDDP

机译:TS-1加CDDP分开治疗晚期胃癌伴肝转移的原发肿瘤完全缓解

获取原文
获取原文并翻译 | 示例
           

摘要

A 62-year-old female patient was hospitalized for general fatigue and appetite loss. Type 3 gastric cancer (moderate differentiated adenocarcinoma) with liver metastasis (S8) and direct invasion to the retro-peritoneal space and duodenal third portion was detected by endoscopic and radiographic examination. This case was judged to be unresectable from these findings. TS-1 plus divided administration of CDDP was performed. TS-1 (100 mg/day) was administrated from day 1 to 21 followed by 14 days rest as one course. CDDP (20 mg/m2) was infused for 2 hours on day 1, 8, and 15. One course was done in the hospital, and the following 2 courses as ambulatory treatment. Grade 2 neutropenia was observed as an adverse reaction. At the completion of 3 courses, partial response in the primary tumor, complete response in the duodenal third portion and no change in the liver metastasis were assessed by examination. Because of this remarkable down-staging, distal gastrectomy and radiofrequency ablation (RFA) for livermetastasis were performed. There was no evidence of direct invasion to the other organs from the primary tumor in intraoperative findings. Pathological examination revealed the disappearance of carcinoma cell in the resected stomach and the surrounding lymphnodes. In conclusion, this chemotherapy regimen has an excellent antitumor effect with low toxicities. Therefore, this regimen was comparatively safe for outpatients and was an effective neo-adjuvant chemotherapy.
机译:一名62岁的女性患者因全身疲劳和食欲不振而住院。通过内窥镜检查和影像学检查发现有肝转移(S8)并直接侵袭到腹膜后间隙和十二指肠第三部分的3型胃癌(中度分化腺癌)。从这些调查结果中判定此案不可切除。 TS-1加上CDDP的分开给药。从第1天到第21天服用TS-1(100毫克/天),然后作为一个疗程休息14天。在第1、8和15天,将CDDP(20 mg / m2)输注2小时,在医院进行了一个疗程,随后的两个疗程作为门诊治疗。观察到2级嗜中性白血球减少症为不良反应。在3个疗程结束时,通过检查评估了原发性肿瘤的部分缓解,十二指肠第三部分的完全缓解以及肝转移的改变。由于这种显着的降级,进行了远端胃切除术和射频消融(RFA)治疗肝转移。术中没有证据显示原发肿瘤直接侵袭其他器官。病理检查发现切除的胃及周围淋巴结中癌细胞消失。总之,该化疗方案具有优异的抗肿瘤作用且毒性低。因此,该方案对门诊患者相对安全,是一种有效的新辅助化疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号